Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03016312
Brief Title: A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen (IMbassador250)

First Submitted : January 9, 2017
First Submitted that Met QC Criteria : January 9, 2017
First Posted : January 10, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : January 13, 2020
Last Update Posted : January 14, 2020